Principal component analysis of the Cytokine and Chemokine response to human traumatic brain injury

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Helmy, Adel ^a   Antoniades, Chrystalina A ^b   Guilfoyle, Mathew R ^a   Carpenter, Keri L H ^a   Hutchinson, Peter J ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON; CD135 ANTIGEN; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; FRACTALKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MONOCYTE CHEMOTACTIC PROTEIN 1;

ARTICLE; BLOOD ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DATA ANALYSIS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; INFLAMMATION; INTERMETHOD COMPARISON; MICRODIALYSIS; PARTIAL LEAST SQUARES REGRESSION; PRINCIPAL COMPONENT ANALYSIS; PROTEIN DETERMINATION; SCORING SYSTEM; STATISTICAL MODEL; TISSUE DISTRIBUTION; TRAUMATIC BRAIN INJURY;

BRAIN INJURIES; CHEMOKINES; CYTOKINES; HUMANS; PRINCIPAL COMPONENT ANALYSIS;

EID: 84862639108     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039677     Document Type: Article

References (61)

1. Andriessen TM, Jacobs B, Vos PE, (2010) Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J Cell Mol Med 14: 2381-2392.
2. Schmidt OI, Heyde CE, Ertel W, Stahel PF, (2005) Closed head injury-an inflammatory disease? Brain Res Brain Res Rev 48: 388-399.
3. Morganti-Kossmann MC, Satgunaseelan L, Bye N, Kossmann T, (2007) Modulation of immune response by head injury. Injury 38: 1392-1400.
4. Loane DJ, Byrnes KR, (2010) Role of microglia in neurotrauma. Neurotherapeutics 7: 366-377.
5. Helmy A, Simoni MG, Guilfoyle MR, Carpenter KL, Hutchinson PJ, (2011) Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury. Prog Neurobiol.
6. Helmy A, Carpenter KL, Menon DK, Pickard JD, Hutchinson PJ, (2011) The cytokine response to human traumatic brain injury: temporal profiles and evidence for cerebral parenchymal production. J Cereb Blood Flow Metab 31: 658-670.
7. Stein DM, Kufera JA, Lindell A, Murdock KR, Menaker J, et al. (2011) Association of CSF biomarkers and secondary insults following severe traumatic brain injury. Neurocrit Care 14: 200-207.
8. Stein DM, Lindell A, Murdock KR, Kufera JA, Menaker J, et al. (2011) Relationship of serum and cerebrospinal fluid biomarkers with intracranial hypertension and cerebral hypoperfusion after severe traumatic brain injury. J Trauma 70: 1096-1103.
9. Hergenroeder GW, Moore AN, McCoy JP Jr, Samsel L, Ward NH 3rd, et al (2010) Serum IL-6: a candidate biomarker for intracranial pressure elevation following isolated traumatic brain injury. J Neuroinflammation 7: 19.
10. Hayakata T, Shiozaki T, Tasaki O, Ikegawa H, Inoue Y, et al. (2004) Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 22: 102-107.
11. Shiozaki T, Hayakata T, Tasaki O, Hosotubo H, Fuijita K, et al. (2005) Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock 23: 406-410.
12. Kirchhoff C, Buhmann S, Bogner V, Stegmaier J, Leidel BA, et al. (2008) Cerebrospinal IL-10 concentration is elevated in non-survivors as compared to survivors after severe traumatic brain injury. Eur J Med Res 13: 464-468.
13. Pleines UE, Morganti-Kossmann MC, Rancan M, Joller H, Trentz O, et al. (2001) S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma 18: 491-498.
14. Pleines UE, Stover JF, Kossmann T, Trentz O, Morganti-Kossmann MC, (1998) Soluble ICAM-1 in CSF coincides with the extent of cerebral damage in patients with severe traumatic brain injury. J Neurotrauma 15: 399-409.
15. Singhal A, Baker AJ, Hare GM, Reinders FX, Schlichter LC, et al. (2002) Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury. J Neurotrauma 19: 929-937.
16. Chiaretti A, Antonelli A, Mastrangelo A, Pezzotti P, Tortorolo L, et al. (2008) Interleukin-6 and nerve growth factor upregulation correlates with improved outcome in children with severe traumatic brain injury. J Neurotrauma 25: 225-234.
17. Chiaretti A, Barone G, Riccardi R, Antonelli A, Pezzotti P, et al. (2009) NGF, DCX, and NSE upregulation correlates with severity and outcome of head trauma in children. Neurology 72: 609-616.
18. Hillman J, Aneman O, Persson M, Andersson C, Dabrosin C, et al. (2007) Variations in the response of interleukins in neurosurgical intensive care patients monitored using intracerebral microdialysis. J Neurosurg 106: 820-825.
19. Hutchinson PJ, O'Connell MT, Rothwell NJ, Hopkins SJ, Nortje J, et al. (2007) Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. J Neurotrauma 24: 1545-1557.
20. Pinteaux E, Trotter P, Simi A, (2009) Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation. Cytokine 45: 1-7.
21. Eriksson L, Antti H, Gottfries J, Holmes E, Johansson E, et al. (2004) Using chemometrics for navigating in the large data sets of genomics, proteomics, and metabonomics (gpm). Anal Bioanal Chem 380: 419-429.
22. Eriksson L JE, Kettaneh-Wold N, Wold S, (2001) Multi- and megavariate data analysis-principles and applications.: Umetrics AB.
23. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikstrom J, et al. (2006) Multi- and megavariate data analysis, Part II, Advanced applications and method extensions, second revised and enlarged edition. Umetrics AB.
24. Boulesteix AL, Strimmer K, (2007) Partial least squares: a versatile tool for the analysis of high-dimensional genomic data. Brief Bioinform 8: 32-44.
25. Saatman KE, Duhaime AC, Bullock R, Maas AI, Valadka A, et al. (2008) Classification of traumatic brain injury for targeted therapies. J Neurotrauma 25: 719-738.
26. Medzhitov R, (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135-145.
27. Chao CC, Hu S, Ehrlich L, Peterson PK, (1995) Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Brain Behav Immun 9: 355-365.
28. Downen M, Amaral TD, Hua LL, Zhao ML, Lee SC, (1999) Neuronal death in cytokine-activated primary human brain cell culture: role of tumor necrosis factor-alpha. Glia 28: 114-127.
29. Andre R, Pinteaux E, Kimber I, Rothwell NJ, (2005) Differential actions of IL-1 alpha and IL-1 beta in glial cells share common IL-1 signalling pathways. Neuroreport 16: 153-157.
30. Patel HC, Bouamra O, Woodford M, King AT, Yates DW, et al. (2005) Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: an observational study. Lancet 366: 1538-1544.
31. Simi A, Tsakiri N, Wang P, Rothwell NJ, (2007) Interleukin-1 and inflammatory neurodegeneration. Biochem Soc Trans 35: 1122-1126.
32. Deshmane SL, Kremlev S, Amini S, Sawaya BE, (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313-326.
33. Mosser DM, Edwards JP, (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969.
34. Murray PJ, Wynn TA, (2011) Obstacles and opportunities for understanding macrophage polarization. J Leukoc Biol 89: 557-563.
35. Dong C, (2008) TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 8: 337-348.
36. Semple BD, Bye N, Ziebell JM, Morganti-Kossmann MC, (2010) Deficiency of the chemokine receptor CXCR2 attenuates neutrophil infiltration and cortical damage following closed head injury. Neurobiol Dis 40: 394-403.
37. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC, (2010) Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cereb Blood Flow Metab 30: 769-782.
38. Semple BD, Frugier T, Morganti-Kossmann MC, (2010) CCL2 modulates cytokine production in cultured mouse astrocytes. J Neuroinflammation 7: 67.
39. Yao H, Bethel-Brown C, Li CZ, Buch SJ, (2010) HIV neuropathogenesis: a tight rope walk of innate immunity. J Neuroimmune Pharmacol 5: 489-495.
40. Ceulemans AG, Zgavc T, Kooijman R, Hachimi-Idrissi S, Sarre S, et al. (2010) The dual role of the neuroinflammatory response after ischemic stroke: modulatory effects of hypothermia. J Neuroinflammation 7: 74.
41. Helmy A, Carpenter KL, Hutchinson PJ, (2007) Microdialysis in the human brain and its potential role in the development and clinical assessment of drugs. Curr Med Chem 14: 1525-1537.
42. Helmy A, Timofeev I, Palmer CR, Gore A, Menon DK, et al. (2010) Hierarchical log linear analysis of admission blood parameters and clinical outcome following traumatic brain injury. Acta Neurochir (Wien) 152: 953-957.
43. Shohami E, Ginis I, Hallenbeck JM, (1999) Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev 10: 119-130.
44. Popovich PG, Longbrake EE, (2008) Can the immune system be harnessed to repair the CNS? Nat Rev Neurosci 9: 481-493.
45. Swartz KR, Liu F, Sewell D, Schochet T, Campbell I, et al. (2001) Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 896: 86-95.
46. Marmarou A, Lu J, Butcher I, McHugh GS, Murray GD, et al. (2007) Prognostic value of the Glasgow Coma Scale and pupil reactivity in traumatic brain injury assessed pre-hospital and on enrollment: an IMPACT analysis. J Neurotrauma 24: 270-280.
47. Mushkudiani NA, Engel DC, Steyerberg EW, Butcher I, Lu J, et al. (2007) Prognostic value of demographic characteristics in traumatic brain injury: results from the IMPACT study. J Neurotrauma 24: 259-269.
48. Murray GD, Butcher I, McHugh GS, Lu J, Mushkudiani NA, et al. (2007) Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma 24: 329-337.
49. Timofeev I, Carpenter KL, Nortje J, Al-Rawi PG, O'Connell MT, et al. (2011) Cerebral extracellular chemistry and outcome following traumatic brain injury: a microdialysis study of 223 patients. Brain 134: 484-494.
50. Van Beek JG, Mushkudiani NA, Steyerberg EW, Butcher I, McHugh GS, et al. (2007) Prognostic value of admission laboratory parameters in traumatic brain injury: results from the IMPACT study. J Neurotrauma 24: 315-328.
51. Ramon J, Fierens D, Guiza F, Meyfroidt G, Blockeel H, et al. (2007) Mining data from intensive care patients. Advanced Engineering Informatics 21: 243-256.
52. Gasteiger J, (2006) Chemoinformatics: a new field with a long tradition. Anal Bioanal Chem 384: 57-64.
53. Hanrieder J, Wetterhall M, Enblad P, Hillered L, Bergquist J, (2009) Temporally resolved differential proteomic analysis of human ventricular CSF for monitoring traumatic brain injury biomarker candidates. J Neurosci Methods 177: 469-478.
54. Frugier T, Morganti-Kossmann MC, O'Reilly D, McLean CA, (2010) In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. J Neurotrauma 27: 497-507.
55. Dahlin AP, Wetterhall M, Caldwell KD, Larsson A, Bergquist J, et al. (2010) Methodological aspects on microdialysis protein sampling and quantification in biological fluids: an in vitro study on human ventricular CSF. Anal Chem 82: 4376-4385.
56. Helmy A, Carpenter KL, Skepper JN, Kirkpatrick PJ, Pickard JD, et al. (2009) Microdialysis of cytokines: methodological considerations, scanning electron microscopy, and determination of relative recovery. J Neurotrauma 26: 549-561.
57. Mellergard P, Aneman O, Sjogren F, Saberg C, Hillman J, (2011) Differences in cerebral extracellular response of interleukin-1beta, interleukin-6, and interleukin-10 after subarachnoid hemorrhage or severe head trauma in humans. Neurosurgery 68: 12-19; discussion 19.
58. Marcus HJ, Carpenter KL, Price SJ, Hutchinson PJ, (2010) In vivo assessment of high-grade glioma biochemistry using microdialysis: a study of energy-related molecules, growth factors and cytokines. J Neurooncol 97: 11-23.
59. Stenken JA, Church MK, Gill CA, Clough GF, (2010) How minimally invasive is microdialysis sampling? A cautionary note for cytokine collection in human skin and other clinical studies. AAPS J 12: 73-78.
60. Mellergard P, Aneman O, Sjogren F, Pettersson P, Hillman J, (2008) Changes in extracellular concentrations of some cytokines, chemokines, and neurotrophic factors after insertion of intracerebral microdialysis catheters in neurosurgical patients. Neurosurgery 62: 151-157; discussion 157-158.
61. Bellander BM, Cantais E, Enblad P, Hutchinson P, Nordstrom CH, et al. (2004) Consensus meeting on microdialysis in neurointensive care. Intensive Care Med 30: 2166-2169.